Kamada KMDA
NASDAQ KMDA
$8.31 +0.11 (+1.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kamada (KMDA) Profit After Tax (2012 - 2026)

Updated

Kamada's Profit After Tax came in at $11.12 million for the quarter ended Jun 30, 2026, up 50.7% from $7.38 million a year earlier and up 67.2% from the prior quarter.

Analysis

Kamada (KMDA) Profit After Tax (2012 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Kamada reported Profit After Tax of $31.11 million, up 27.1% year-over-year; for the year ended Dec 31, 2025, it came in at $26.74 million, up 84.9% from the prior year.

  • Profit After Tax carries a five-year compound annual growth rate of 9.3% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Profit After Tax was $14.46 million in the year ended Dec 31, 2024 (+68.7%), $8.57 million in the year ended Dec 31, 2023, -$2.2 million in the year ended Dec 31, 2022 and -$2.23 million in the year ended Dec 31, 2021.
  • The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Profit After Tax since the quarter ended Dec 31, 2018.
  • Year-over-year, Profit After Tax increased in six of the last eight quarters, with growth averaging 61.6%.
  • The fastest year-over-year change in Profit After Tax over five years came in the quarter ended Sep 30, 2023 (growth of 565.9%), and the weakest in the quarter ended Mar 31, 2026 (a decline of 28.2%).
  • Business Quant data shows KMDA's Profit After Tax at $6.65 million (quarter ended Mar 31, 2026), $5.91 million (quarter ended Dec 31, 2025) and $7.44 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 5.53 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.62 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.28 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 3.09 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.38 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -10.50 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -246.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.10 Bn
10 Kamada 488.02 Mn 197.08 Mn 22.47 Mn 11.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.12 Mn
Mar 31, 2026 6.65 Mn
Dec 31, 2025 5.91 Mn
Sep 30, 2025 7.44 Mn
Jun 30, 2025 7.38 Mn
Mar 31, 2025 9.26 Mn
Dec 31, 2024 3.81 Mn
Sep 30, 2024 4.03 Mn
Jun 30, 2024 4.55 Mn
Mar 31, 2024 2.51 Mn
Dec 31, 2023 5.06 Mn
Sep 30, 2023 3.22 Mn
Jun 30, 2023 1.81 Mn
Mar 31, 2023 -1.81 Mn
Dec 31, 2022 2.94 Mn
Sep 30, 2022 484,000.00
Jun 30, 2022 -3.92 Mn
Mar 31, 2022 -1.83 Mn
Dec 31, 2021 -4.66 Mn
Sep 30, 2021 -845,000.00
API Access

Kamada Profit After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=KMDA&period=max&api_key=YOUR_API_KEY